Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nugent

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
Psychopharmacology|January 13, 2011
Gene-environment interactions: early life stress and risk for depressive and anxiety disordersNicole R Nugent, Audrey R Tyrka, Linda L Carpenter, et al.
Journal of Health & Social Policy|September 28, 2004
Policy recommendations for the use of victim-offender mediation to redress criminal actionsMona William-Hayes, Catherine N Dulmus, William R Nugent, et al.
Journal of Traumatic Stress|October 18, 2012
Pharmacological secondary prevention of PTSD in youth: challenges and opportunities for advancementMatthew A Maccani, Douglas L Delahanty, Nicole R Nugent, et al.
JMIR Formative Research|December 5, 2023
Designing a Clinician-Centered Wearable Data Dashboard (CarePortal): Participatory Design StudyShehjar Sadhu, Dhaval Solanki, Leslie A Brick, et al.
The Pediatric Infectious Disease Journal|June 1, 1994
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, J Moye, J Korelitz, et al.
Biostatistics (Oxford, England)|August 2, 2023
Blurring cluster randomized trials and observational studies: Two-Stage TMLE for subsampling, missingness, and few independent unitsJoshua R Nugent, Carina Marquez, Edwin D Charlebois, et al.
JAMA|August 1, 1992
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, J Moye, J Bethel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995
Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, J Korelitz, S Pelton, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 20, 2011
Quantifying risks of preterm birth in the Arkansas Medicaid population, 2001-2005M S Wingate, J Bronstein, R W Hall, et al.
Journal of Pediatric Psychology|December 8, 2009
Sexual abuse and sexual risk behavior: beyond the impact of psychiatric problemsChristopher D Houck, Nicole R Nugent, Celia M Lescano, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Psychopharmacology|January 13, 2011
Gene-environment interactions: early life stress and risk for depressive and anxiety disordersNicole R Nugent, Audrey R Tyrka, Linda L Carpenter, et al.
Journal of Health & Social Policy|September 28, 2004
Policy recommendations for the use of victim-offender mediation to redress criminal actionsMona William-Hayes, Catherine N Dulmus, William R Nugent, et al.
Journal of Traumatic Stress|October 18, 2012
Pharmacological secondary prevention of PTSD in youth: challenges and opportunities for advancementMatthew A Maccani, Douglas L Delahanty, Nicole R Nugent, et al.
JMIR Formative Research|December 5, 2023
Designing a Clinician-Centered Wearable Data Dashboard (CarePortal): Participatory Design StudyShehjar Sadhu, Dhaval Solanki, Leslie A Brick, et al.
The Pediatric Infectious Disease Journal|June 1, 1994
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, J Moye, J Korelitz, et al.
Biostatistics (Oxford, England)|August 2, 2023
Blurring cluster randomized trials and observational studies: Two-Stage TMLE for subsampling, missingness, and few independent unitsJoshua R Nugent, Carina Marquez, Edwin D Charlebois, et al.
JAMA|August 1, 1992
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, J Moye, J Bethel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995
Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study GroupL M Mofenson, J Korelitz, S Pelton, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|August 20, 2011
Quantifying risks of preterm birth in the Arkansas Medicaid population, 2001-2005M S Wingate, J Bronstein, R W Hall, et al.
Journal of Pediatric Psychology|December 8, 2009
Sexual abuse and sexual risk behavior: beyond the impact of psychiatric problemsChristopher D Houck, Nicole R Nugent, Celia M Lescano, et al.
Pageof 21